+- 10 shots depending on dosage
There are a number of areas in which TA1 has been studied:
* Viral infections - TA1 is used for chronic hepatitis B and C in some countries. It helps reduce viral load and inflammation. | |
* Immune enhancement - It helps restore immune function in immunocompromised people; useful after certain infections, or in settings of immune suppression. | |
* Cancer support - As an adjunct to cancer therapy: helps improve immune surveillance, potentially supports response to immunotherapy or chemotherapy. | |
* Vaccine adjuvant/ immunocompromised settings - Enhancing vaccine responses, especially in older or immunocompromised individuals. | |
* Sepsis, respiratory infections, acute infections - Some clinical evidence in acute infections; TA1 may help regulate the immune response and reduce damage. |

